ECPC strongly believes that patients must be informed in order to take an active role in the decision-making concerning their treatment. We have developed this tool to allow patients to do so.
A biosimilar is a highly similar copy of an off-patent biological medicine which is already available on the market under a different trademark. Biosimilars have the potential to increase access to medicines by improving the financial sustainability of our healthcare systems.
We encourage you to share this e-learning tool with your network. If you are affected by cancer and you wish to get involved, we encourage you to contact one of our members in your country, the contact details of whom you can find in our members’ database.
You can try the e-learning module here.
Go through each of the six e-learning modules in order and test or further increase your knowledge by using the links below to find even more in-depth information on biosimilars.